Vermont Center on Behavior and Health, University of Vermont, United States of America; Department of Psychiatry, University of Vermont, United States of America.
Vermont Center on Behavior and Health, University of Vermont, United States of America; Rehabilitation Institute, Southern Illinois University, United States of America.
Prev Med. 2018 Dec;117:52-60. doi: 10.1016/j.ypmed.2018.08.019. Epub 2018 Aug 23.
This study examined quit rates longitudinally for cigarettes, e-cigarettes, hookah, cigars, and all tobacco products in a U.S. national sample of women aged 18-44 who completed both Wave 1 (W1) and Wave 2 (W2) of the Population Assessment of Tobacco and Health (PATH, 2013-2014, 2014-2015) study (N = 7814). Quit rates were examined among women who transitioned into pregnancy across survey waves, and among a comparable sample of non-pregnant women to provide contextual information about quitting among the broader population of reproductive-aged women. Multiple logistic regression modeling was used to estimate the associations of pregnancy and quitting adjusting for other demographic and psychosocial characteristics. Quit rates among women who were pregnant in W2 were highest for hookah (98.3%), followed by cigars (88.0%), e-cigarettes (81.3%), and lowest for tobacco cigarettes (53.4%). Slightly more than half (58.7%) of women reported quitting use all tobacco products while pregnant. Pregnancy was independently associated with increased odds of quitting hookah (AOR = 52.9, 95%CI = 3.4, 830.2), e-cigarettes (AOR = 21.0, 95%CI = 2.6, 170.3), all tobacco products (AOR = 9.6, 95%CI = 6.4, 14.5), and cigarettes (AOR = 6.5, 95%CI = 4.2, 10.1), although not cigars. Relative to other demographic and psychosocial characteristics, pregnancy was the strongest predictor of quitting use of each tobacco product. While these data indicate that pregnancy has strong, independent associations with quitting a variety of commercially available tobacco products, the comparatively lower quit rates for cigarettes versus other tobacco products underscores the long-standing need for more intensive, multipronged clinical and regulatory interventions to reduce cigarette use among reproductive-aged women.
本研究在一个美国全国样本中,对 18-44 岁的女性进行了纵向研究,这些女性在人口烟草评估 (PATH,2013-2014 年,2014-2015 年) 的第一波 (W1) 和第二波 (W2) 中都完成了调查 (N=7814)。本研究在跨调查波进入妊娠的女性中检查了戒烟率,并在可比的非妊娠女性样本中提供了关于生殖年龄女性更广泛人群戒烟的背景信息。采用多逻辑回归模型来估计妊娠和戒烟的关联,调整了其他人口统计学和心理社会特征。在 W2 期间怀孕的女性中,使用水烟戒烟率最高 (98.3%),其次是雪茄 (88.0%)、电子烟 (81.3%),使用烟草卷烟戒烟率最低 (53.4%)。略多于一半 (58.7%)的女性报告在怀孕期间停止使用所有烟草制品。怀孕与增加使用水烟、电子烟、所有烟草制品和卷烟的戒烟几率独立相关 (AOR=52.9,95%CI=3.4,830.2)、AOR=21.0,95%CI=2.6,170.3)、AOR=9.6,95%CI=6.4,14.5)、AOR=6.5,95%CI=4.2,10.1),但不包括雪茄。与其他人口统计学和心理社会特征相比,怀孕是戒烟的最强预测因素。虽然这些数据表明怀孕与戒烟各种市售烟草产品之间存在很强的独立关联,但与其他烟草制品相比,香烟的戒烟率相对较低,这突显了在生殖年龄女性中减少香烟使用需要更加强烈、多管齐下的临床和监管干预。